ALDH1A1 and non-small cell lung carcinoma: Aldehyde dehydrogenase 1 (ALDH1), a CSC marker, has potential diagnostic and therapeutic implications [119], and ALDH1+ CTCs positivity in patients with NSCLC was found to be associated with the disease stage [120].